Interferon-induced versus chemokine transcripts as lupus biomarkers

Por Crow, Mary K, Kirou, Kyriakos A
Publicado em 2008

A new tool for detection of type I interferon activation in systemic lupus erythematosus

Por Kirou, Kyriakos A, Kalliolias, George D
Publicado em 2010

Belimumab in systemic lupus erythematosus: an update for clinicians

Por Kim, Susan S., Kirou, Kyriakos A., Erkan, Doruk
Publicado em 2012

Targeting of Type I Interferon in Systemic Autoimmune Diseases

Por Crow, Mary K., Olferiev, Mikhail, Kirou, Kyriakos A.
Publicado no Transl Res (2014)

Identification of Candidate Predictors of Lupus Flare

Por Crow, Mary K., Olferiev, Mikhail, Kirou, Kyriakos A.
Publicado no Trans Am Clin Climatol Assoc (2015)

Minimal Change Disease as a Secondary and Reversible Event of a Renal Transplant Case with Systemic Lupus Erythematosus

Por Gkrouzman, Elena, Kirou, Kyriakos A., Seshan, Surya V., Chevalier, James M.
Publicado no Case Rep Nephrol (2015)

Cutting Edge: Autoimmune Disease Risk Variant of STAT4 Confers Increased Sensitivity to IFN-α in Lupus Patients In Vivo

Por Kariuki, Silvia N., Kirou, Kyriakos A., MacDermott, Emma J., Barillas-Arias, Lilliana, Crow, Mary K., Niewold, Timothy B.
Publicado em 2009

Enhanced ROCK Activation in Patients with Systemic Lupus Erythematosus

Por Isgro, Josephine, Gupta, Sanjay, Jacek, Elzbieta, Pavri, Tanya, Duculan, Roland, Kim, Mimi, Kirou, Kyriakos A., Salmon, Jane E., Pernis, Alessandra B.
Publicado em 2013

Increased Serum Type I Interferon Activity in Organ-Specific Autoimmune Disorders: Clinical, Imaging, and Serological Associations

Por Mavragani, Clio P., Niewold, Timothy B., Chatzigeorgiou, Antonis, Danielides, Stamatina, Thomas, Dimitrios, Kirou, Kyriakos A., Kamper, Elli, Kaltsas, Grigorios, Crow, Mary K.
Publicado em 2013

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

Por Spiera, Robert F, Gordon, Jessica K, Mersten, Jamie N, Magro, Cynthia M, Mehta, Mansi, Wildman, Horatio F, Kloiber, Stacey, Kirou, Kyriakos A, Lyman, Stephen, Crow, Mary K
Publicado em 2011

Long interspersed nuclear element-1 retroelements are expressed in patients with systemic autoimmune disease and induce type I interferon

Por Mavragani, Clio P., Sagalovskiy, Irina, Guo, Qiu, Nezos, Adrianos, Kapsogeorgou, Efstathia K., Lu, Pin, Zhou, Jun Liang, Kirou, Kyriakos A., Seshan, Surya V., Moutsopoulos, Haralampos M., Crow, Mary K.
Publicado no Arthritis Rheumatol (2016)

Felty’s Syndrome Autoantibodies Bind to Deiminated Histones and Neutrophil Extracellular Chromatin Traps

Por Dwivedi, Nishant, Upadhyay, Jagriti, Neeli, Indira, Khan, Salar, Pattanaik, Debendra, Myers, Linda, Kirou, Kyriakos A., Hellmich, Bernhard, Knuckley, Bryan, Thompson, Paul R., Crow, Mary K., Mikuls, Ted R., Csernok, Elena, Radic, Marko
Publicado no Arthritis Rheum (2011)

Autoimmune Disease Risk Variant of IFIH1 Is Associated with Increased Sensitivity to IFN-α and Serologic Autoimmunity in Lupus Patients

Por Robinson, Talin, Kariuki, Silvia N., Franek, Beverly S., Kumabe, Marissa, Kumar, Akaash A., Badaracco, Maria, Mikolaitis, Rachel A., Guerrero, Galen, Utset, Tammy O., Drevlow, Barbara E., Zaacks, Laura S., Grober, James S., Cohen, Lewis M., Kirou, Kyriakos A., Crow, Mary K., Jolly, Meenakshi, Niewold, Timothy B.
Publicado em 2011